STAAR Surgical (STAA) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. DOX
6. CRWD
7. ON
8. INSP
9. HNGE
10. SPY

Go back to STAAR Surgical (STAA) Reports In-Line Q3 EPS

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

November 2, 2022 4:01 PM EDT

ICL Units Up 40% Y/Y; Constant Currency Net Sales of $80.0 Million

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 30, 2022.

Third Quarter 2022 Overview

Net Sales of $76.0 Million Up 30% and Constant Currency Net Sales of $80.0 Million Up 37% from the Prior Year Quarter ICL Sales of $72.0 Million Up 33% and... More